Rhythm Biosciences Limited (RHY.AX)
Rhythm Biosciences Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Parkville, VIC, AU. The stock last traded at $0.08, down 2.35% on the session, giving a market capitalisation of $29.4M. Its beta of 0.41 implies it has historically moved less than the broad market.
Rhythm Biosciences Limited functions as a forward-thinking enterprise focused on predictive cancer diagnostics, active across both Australian and global territories. The company's core operations involve the creation, advancement, and market introduction of cutting-edge medical diagnostic technologies. A key innovation is ColoSTAT, their specialized blood test designed for the prompt and reliable identification of colorectal cancer. Established in 2017, the firm's main offices are located in Parkville, Australia.
Rhythm Biosciences Limited is most often compared with the following Healthcare names: